Caris Life Sciences Inc (CAI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2017 | 06-2017 | 03-2017 | 12-2016 | 09-2016 | |
| Sales | 90,161 | 82,692 | 81,506 | 77,274 | 78,472 |
| Cost of Goods | 17,855 | 16,682 | 17,071 | 16,853 | 18,045 |
| Gross Profit | 72,306 | 66,010 | 64,435 | 60,421 | 60,427 |
| Operating Expenses | 41,267 | 41,924 | 46,555 | 48,664 | 53,110 |
| Operating Income | 31,894 | 24,768 | 17,951 | 12,610 | 7,362 |
| Interest Expense | 13,959 | 12,285 | 11,672 | 11,219 | 10,902 |
| Other Income | -449 | 112 | -314 | -247 | -85 |
| Pre-tax Income | 17,486 | 12,595 | 5,965 | 1,144 | -3,625 |
| Income Tax | -101 | -43 | 693 | 524 | 1,826 |
| Net Income Continuous | 17,587 | 12,638 | 5,272 | 620 | -5,451 |
| Net Income | $17,587 | $12,638 | $5,272 | $620 | $-5,451 |
| EPS Basic Total Ops | 0.92 | 0.66 | 0.28 | 0.04 | -0.28 |
| EPS Basic Continuous Ops | 0.92 | 0.66 | 0.28 | 0.04 | -0.28 |
| EPS Diluted Total Ops | 0.90 | 0.65 | 0.27 | 0.04 | -0.28 |
| EPS Diluted Continuous Ops | 0.90 | 0.65 | 0.27 | 0.04 | -0.28 |
| EBITDA(a) | $61,107 | $53,105 | $47,425 | $41,729 | $38,389 |